계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
HLS Therapeutics
company
About
HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycles post - exclusivity.
- 101 - 250
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $91.10M
- Industries
- Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 2014
- Number Of Employee
- 101 - 250
- Operating Status
- Active
HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycles post - exclusivity. HLS ensures the availability of treatments critical to patients and their caregivers with the brand names they trust.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$91.10M
HLS Therapeutics has raised a total of
$91.10M
in funding over 2 rounds. Their latest funding was raised on
Oct 3, 2022 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 3, 2022 | Post-IPO Debt | $91.10M | 1 |
JP Morgan Chase
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
HLS Therapeutics is funded by 1 investors.
JP Morgan Chase
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
JP Morgan Chase
|
Yes | Post-IPO Debt |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
